These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

948 related items for PubMed ID: 24038019

  • 1. Renin-angiotensin system blocking drugs.
    Robles NR, Cerezo I, Hernandez-Gallego R.
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
    [Abstract] [Full Text] [Related]

  • 2. [The future of renin inhibition].
    Uresin AY, Baran E.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [Abstract] [Full Text] [Related]

  • 3. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ, Smith SM, Choksi R.
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [Abstract] [Full Text] [Related]

  • 4. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V, Buksa M, Loza V, Kulic M.
    Med Arh; 2009 Nov; 63(6):343-9. PubMed ID: 20380117
    [Abstract] [Full Text] [Related]

  • 5. [Renin inhibition and the kidney].
    Ecder T.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [Abstract] [Full Text] [Related]

  • 6. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
    Weber MA, Giles TD.
    Rev Cardiovasc Med; 2006 Oct; 7(2):45-54. PubMed ID: 16915123
    [Abstract] [Full Text] [Related]

  • 7. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P, Gentile G, Angeli F, Reboldi G.
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [Abstract] [Full Text] [Related]

  • 8. Renin inhibition--benefit beyond hypertension control.
    Kher V.
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 11. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 12. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.
    Bomback AS, Toto R.
    Am J Hypertens; 2009 Oct; 22(10):1032-40. PubMed ID: 19661925
    [Abstract] [Full Text] [Related]

  • 13. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
    Ram CV.
    Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410
    [Abstract] [Full Text] [Related]

  • 14. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
    Pimenta E, Oparil S.
    Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of renin: an updated review of the development of renin inhibitors.
    Li YC.
    Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
    [Abstract] [Full Text] [Related]

  • 16. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 17. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
    López V, Martin M, Cobelo C, Aranda P, Cabello M, Sola E, Gutierrez C, Burgos D, Martínez D, Hernandez D.
    Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559
    [Abstract] [Full Text] [Related]

  • 18. Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends.
    Gullapalli N, Bloch MJ, Basile J.
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):359-73. PubMed ID: 20965951
    [Abstract] [Full Text] [Related]

  • 19. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
    Tempelhof MW.
    South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
    [No Abstract] [Full Text] [Related]

  • 20. Aliskiren, the future of renin-angiotensin system blockade?
    Uresin Y, Mehtar Bozkurt M, Sabirli S, Ozunal ZG.
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.